A Six-Day, Lifestyle-Based Immersion Program Mitigates Cardiovascular Risk Factors and Induces Shifts in Gut Microbiota, Specifically Lachnospiraceae, Ruminococcaceae, Faecalibacterium prausnitzii: A Pilot Study

Cardiovascular disease (CVD) prevalence remains elevated globally. We have previously shown that a one-week lifestyle “immersion program” leads to clinical improvements and sustained improvements in quality of life in moderate to high atherosclerotic CVD (ASCVD) risk individuals. In a subsequent year of this similarly modeled immersion program, we again collected markers of cardiovascular health and, additionally, evaluated intestinal microbiome composition. ASCVD risk volunteers (n = 73) completed the one-week “immersion program” involving nutrition (100% plant-based foods), stress management education, and exercise. Anthropometric measurements and CVD risk factors were compared at baseline and post intervention. A subgroup (n = 22) provided stool, which we analyzed with 16S rRNA sequencing. We assessed abundance changes within-person, correlated the abundance shifts with clinical changes, and inferred functional pathways using PICRUSt. Reductions in blood pressure, total cholesterol, and triglycerides, were observed without reduction in weight. Significant increases in butyrate producers were detected, including Lachnospiraceae and Oscillospirales. Within-person, significant shifts in relative abundance (RA) occurred, e.g., increased Lachnospiraceae (+58.8% RA, p = 0.0002), Ruminococcaceae (+82.1%, p = 0.0003), Faecalibacterium prausnitzii (+54.5%, p = 0.002), and diversification and richness. Microbiota changes significantly correlated with body mass index (BMI), blood pressure (BP), cholesterol, high-sensitivity C-reactive protein (hsCRP), glucose, and trimethylamine N-oxide (TMAO) changes. Pairwise decreases were inferred in microbial genes corresponding to cancer, metabolic disease, and amino acid metabolism. This brief lifestyle-based intervention improved lipids and BP and enhanced known butyrate producers, without significant weight loss. These results demonstrate a promising non-pharmacological preventative strategy for improving cardiovascular health.

[1]  J. Sonnenburg,et al.  A randomized crossover trial on the effect of plant-based compared with animal-based meat on trimethylamine-N-oxide and cardiovascular disease risk factors in generally healthy adults: Study With Appetizing Plantfood-Meat Eating Alternative Trial (SWAP-MEAT). , 2020, The American journal of clinical nutrition.

[2]  Mochao Xiao,et al.  Butyrate mitigates TNF-α-induced attachment of monocytes to endothelial cells , 2020, Journal of Bioenergetics and Biomembranes.

[3]  E. Handberg,et al.  Benefit of One Week Immersion in Lifestyle-based Program for Sustainable Improvements in Cardiovascular Risk Factors Over Time , 2020, International journal of disease reversal and prevention.

[4]  Edoardo Pasolli,et al.  Mediterranean diet intervention in overweight and obese subjects lowers plasma cholesterol and causes changes in the gut microbiome and metabolome independently of energy intake , 2020, Gut.

[5]  Yoke Keong Yong,et al.  Endothelial Dysfunction in Obesity-Induced Inflammation: Molecular Mechanisms and Clinical Implications , 2020, Biomolecules.

[6]  L. Lerman,et al.  Coronary artery disease is associated with an altered gut microbiome composition , 2020, PloS one.

[7]  Francesca N. Delling,et al.  Heart Disease and Stroke Statistics—2020 Update: A Report From the American Heart Association , 2020, Circulation.

[8]  C. Gazzaruso,et al.  The role of gut microbiota in obesity, diabetes mellitus, and effect of metformin: new insights into old diseases. , 2019, Current opinion in pharmacology.

[9]  K. Jaworska,et al.  TMA (trimethylamine), but not its oxide TMAO (trimethylamine-oxide), exerts hemodynamic effects - implications for interpretation of cardiovascular actions of gut microbiome. , 2019, Cardiovascular research.

[10]  J. Ilonen,et al.  Genetic risk for autoimmunity is associated with distinct changes in the human gut microbiome , 2019, Nature Communications.

[11]  J. Coresh,et al.  Plant‐Based Diets Are Associated With a Lower Risk of Incident Cardiovascular Disease, Cardiovascular Disease Mortality, and All‐Cause Mortality in a General Population of Middle‐Aged Adults , 2019, Journal of the American Heart Association.

[12]  Shimin Zhao,et al.  Faecalibacterium prausnitzii produces butyrate to decrease c-Myc-related metabolism and Th17 differentiation by inhibiting histone deacetylase 3. , 2019, International immunology.

[13]  A. Gabrielsen,et al.  hsCRP Level and the Risk of Death or Recurrent Cardiovascular Events in Patients With Myocardial Infarction: a Healthcare‐Based Study , 2019, Journal of the American Heart Association.

[14]  Jennifer C. Drew,et al.  PIME: a package for discovery of novel differences among microbial communities , 2019, bioRxiv.

[15]  Francesca N. Delling,et al.  Heart Disease and Stroke Statistics—2019 Update: A Report From the American Heart Association , 2019, Circulation.

[16]  C. Morillas,et al.  Dietary weight loss intervention improves subclinical atherosclerosis and oxidative stress markers in leukocytes of obese humans , 2019, International Journal of Obesity.

[17]  T. Schmidt,et al.  Dynamics of Human Gut Microbiota and Short-Chain Fatty Acids in Response to Dietary Interventions with Three Fermentable Fibers , 2018, mBio.

[18]  S. Bultman Bacterial butyrate prevents atherosclerosis , 2018, Nature Microbiology.

[19]  Houkai Li,et al.  The Role of Gut Microbiota in Atherosclerosis and Hypertension , 2018, Front. Pharmacol..

[20]  F. Hu,et al.  Cardiovascular Disease Prevention by Diet Modification: JACC Health Promotion Series. , 2018, Journal of the American College of Cardiology.

[21]  Wilbert S Aronow,et al.  2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. , 2018, Hypertension.

[22]  J. Salas-Salvadó,et al.  Mediterranean Diet and Cardiovascular Disease Prevention: What Do We Know? , 2018, Progress in cardiovascular diseases.

[23]  Meghan Coakley McCarthy,et al.  Nephele: a cloud platform for simplified, standardized and reproducible microbiome data analysis , 2018, Bioinform..

[24]  L. Caulfield,et al.  Healthy Plant-Based Diets Are Associated with Lower Risk of All-Cause Mortality in US Adults. , 2018, The Journal of nutrition.

[25]  I. Björck,et al.  Improvement in cardiometabolic risk markers following a multifunctional diet is associated with gut microbial taxa in healthy overweight and obese subjects , 2017, European Journal of Nutrition.

[26]  Xun Xu,et al.  The gut microbiome in atherosclerotic cardiovascular disease , 2017, Nature Communications.

[27]  M. Carroll,et al.  Total and High-density Lipoprotein Cholesterol in Adults: United States, 2015-2016. , 2017, NCHS data brief.

[28]  N. Barnard,et al.  Association between plant-based diets and plasma lipids: a systematic review and meta-analysis , 2017, Nutrition reviews.

[29]  P. Whelton,et al.  Systolic Blood Pressure Reduction and Risk of Cardiovascular Disease and Mortality: A Systematic Review and Network Meta-analysis , 2017, JAMA cardiology.

[30]  R. Hajar Risk Factors for Coronary Artery Disease: Historical Perspectives , 2017, Heart views : the official journal of the Gulf Heart Association.

[31]  Jasmine Chong,et al.  MicrobiomeAnalyst: a web-based tool for comprehensive statistical, visual and meta-analysis of microbiome data , 2017, Nucleic Acids Res..

[32]  C. Pepine,et al.  The Gut, Its Microbiome, and Hypertension , 2017, Current Hypertension Reports.

[33]  T. Lobstein,et al.  Interventions that cause weight loss and the impact on cardiovascular risk factors: a systematic review and meta‐analysis , 2016, Obesity reviews : an official journal of the International Association for the Study of Obesity.

[34]  Namrata Iyer Methods in microbiome research , 2016, Lab Animal.

[35]  A. Haslberger,et al.  Gut Microbiota of Obese, Type 2 Diabetic Individuals is Enriched in Faecalibacterium prausnitzii, Akkermansia muciniphila and Peptostreptococcus anaerobius after Weight Loss. , 2016, Endocrine, metabolic & immune disorders drug targets.

[36]  F. Schick,et al.  Relationship of Serum Trimethylamine N-Oxide (TMAO) Levels with early Atherosclerosis in Humans , 2016, Scientific Reports.

[37]  Paul J. McMurdie,et al.  DADA2: High resolution sample inference from Illumina amplicon data , 2016, Nature Methods.

[38]  S. Hazen,et al.  Gut Microbial Metabolite TMAO Enhances Platelet Hyperreactivity and Thrombosis Risk , 2016, Cell.

[39]  D. Mozaffarian Dietary and Policy Priorities for Cardiovascular Disease, Diabetes, and Obesity: A Comprehensive Review , 2016, Circulation.

[40]  W. D. de Vos,et al.  Akkermansia muciniphila Adheres to Enterocytes and Strengthens the Integrity of the Epithelial Cell Layer , 2015, Applied and Environmental Microbiology.

[41]  F. Rey,et al.  Intestinal Microbiota Composition Modulates Choline Bioavailability from Diet and Accumulation of the Proatherogenic Metabolite Trimethylamine-N-Oxide , 2015, mBio.

[42]  Olli Simell,et al.  Bacteroides dorei dominates gut microbiome prior to autoimmunity in Finnish children at high risk for type 1 diabetes , 2014, Front. Microbiol..

[43]  W. Huber,et al.  Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2 , 2014, Genome Biology.

[44]  Dolores Corella,et al.  SUPPLEMENT Proceedings of the IUNS 20 th Congress of Nutrition Mediterranean Diet and Cardiovascular Health : Teachings of the PREDIMED Study 1 – 3 , 2014 .

[45]  Jesse R. Zaneveld,et al.  Predictive functional profiling of microbial communities using 16S rRNA marker gene sequences , 2013, Nature Biotechnology.

[46]  A. Gasbarrini,et al.  Commensal Clostridia: leading players in the maintenance of gut homeostasis , 2013, Gut Pathogens.

[47]  Lucie Geurts,et al.  Cross-talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesity , 2013, Proceedings of the National Academy of Sciences.

[48]  Susan Holmes,et al.  phyloseq: An R Package for Reproducible Interactive Analysis and Graphics of Microbiome Census Data , 2013, PloS one.

[49]  M. Svendsen,et al.  Changes in Body Composition, Cardiovascular Disease Risk Factors, and Eating Behavior after an Intensive Lifestyle Intervention with High Volume of Physical Activity in Severely Obese Subjects: A Prospective Clinical Controlled Trial , 2013, Journal of obesity.

[50]  Pelin Yilmaz,et al.  The SILVA ribosomal RNA gene database project: improved data processing and web-based tools , 2012, Nucleic Acids Res..

[51]  C. Fryar,et al.  Prevalence of uncontrolled risk factors for cardiovascular disease: United States, 1999-2010. , 2012, NCHS data brief.

[52]  Rob Knight,et al.  Using QIIME to Analyze 16S rRNA Gene Sequences from Microbial Communities , 2011, Current protocols in bioinformatics.

[53]  D. Schuppan,et al.  Identification of Rothia Bacteria as Gluten-Degrading Natural Colonizers of the Upper Gastro-Intestinal Tract , 2011, PloS one.

[54]  C. Huttenhower,et al.  Metagenomic biomarker discovery and explanation , 2011, Genome Biology.

[55]  P. Harris,et al.  Research electronic data capture (REDCap) - A metadata-driven methodology and workflow process for providing translational research informatics support , 2009, J. Biomed. Informatics.

[56]  G. Casella,et al.  Influence of Fecal Sample Storage on Bacterial Community Diversity , 2009, The open microbiology journal.

[57]  K. Gould,et al.  Intensive lifestyle changes for reversal of coronary heart disease. , 1998, JAMA.

[58]  Daming Zuo,et al.  Gut Microbiota and Immune Responses. , 2020, Advances in experimental medicine and biology.

[59]  Jian Yan,et al.  Trimethylamine‐N‐oxide (TMAO) response to animal source foods varies among healthy young men and is influenced by their gut microbiota composition: A randomized controlled trial , 2017, Molecular nutrition & food research.

[60]  C. Mackay,et al.  Diet, gut microbiota and immune responses , 2010, Nature Immunology.